Page 3 - Prnewswire Carisma Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

/PRNewswire/ Carisma Therapeutics Inc. (NASDAQ: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and.

United statesJohn hohnekerSteven kellyShveta digheChidozie ugwumbaPrnewswire carisma therapeutics incCarisma therapeutics incModerna tx incCompany annual report on formDrug administrationSesen bio incExchange commissionBoard of directors the companyWhile the companyChief executive officerPipeline updates

First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration

First lead candidate to address a solid tumor indication with significant unmet medical need Supportive pre-clinical proof of concept data reported at SITC 2023 that demonstrated feasibility,.

United statesShveta digheMichael klichinskyLin gueyModerna incTherapeutics research venturesExchange commissionExchange commission onCompany quarterly report on formCarisma therapeutics incPrnewswire carisma therapeutics incChief scientific officerCombining carismaPrivate securities litigation reform actQuarterly report

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael klichinskySteven kellySociety for immunotherapy of cancer annual meetingExchange commissionCarisma therapeutics incCompany quarterly report on formPrnewswire carisma therapeutics incDrug administrationInvestigational new drugStudy may proceedChief executive officerAnnual meetingChief scientific officerPrivate securities litigation reform actQuarterly report

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSteven kellyCompany investor eventsCarisma therapeutics incExchange commissionCompany quarterly report on formPrnewswire carisma therapeutics incChief executive officerAnnual evercoreInvestor eventsInvestor relationsPrivate securities litigation reform actQuarterly report

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesSteven kellyCarisma therapeutics incExchange commissionExchange commission onPrnewswire carisma therapeutics incCompany investor eventsCompany quarterly report on formChief executive officerAnnual evercoreInvestor eventsInvestor relationsPrivate securities litigation reform actQuarterly report